| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |